Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.

导出 LinkOut

翻译打印收藏纠错

第一作者： Florette K,Treurnicht

第一单位： Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.

作者： Florette K,Treurnicht ^[1] ; Amelia,Buys ^[1] ; Stefano,Tempia ^[2] ; Mpho,Seleka ^[3] ; Adam L,Cohen ^[1] ; Sibongile,Walaza ^[2] ; Allison J,Glass ^[4] ; Inéz,Rossouw ^[1] ; Johanna,McAnerney ^[5] ; Lucille,Blumberg ^[6] ; Cheryl,Cohen ^[7] ; Marietjie,Venter ^[1]

作者单位： Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa. ^[1] Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia. ^[2] Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa. ^[3] Department of Immunization, Vaccines and Biologicals, Global Immunization Monitoring and Surveillance, Expanded Programme on Immunization, World Health Organization, Geneva, Switzerland. ^[4] Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa. ^[5] Department of Molecular Pathology, Lancet Laboratories, Johannesburg, South Africa. ^[6] PathCare Laboratories, PathCare Park, Cape Town, South Africa. ^[7] Division of Public Health Surveillance and Response, National Institute of Communicable Diseases, Johannesburg, South Africa. ^[8] Department of Medical Virology, Emerging Arbo-and Respiratory Virus Program, University of Pretoria, Pretoria, South Africa. ^[9] Tshwane Academic Division, National Health Laboratory Service, Pretoria, South Africa. ^[10]

关键词 South Africa influenza oseltamivir susceptibility